CG Oncology, Inc. (CGON) stock
CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$84.78+10.38 (+13.95%)
Close on Nov 16, 2026Market cap $7.51BP/E –Yield –
CG Oncology EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for CG Oncology
CG Oncology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?